Size-controlled biodegradable nanoparticles: Preparation and size-dependent cellular uptake and tumor cell growth inhibition

Colloids and Surfaces B: Biointerfaces

Volumn 122, Issue , 2014, Pages 545-551

  Choi, Jin Seok ^a,b   Cao, Jiafu ^a   Naeem, Muhammad ^a   Noh, Jinki ^a   Hasan, Nurhasni ^a   Choi, Hoo Kyun ^b   Yoo, Jin Wook ^a  

^a Pusan National University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Biodegradable nanoparticles; Cellular uptake; Particle size; Tumor cell growth inhibiton

Indexed keywords

BIODEGRADABLE NANOPARTICLE; CELLULAR UPTAKE; GROWTH INHIBITION; SIZE DEPENDENT; TUMOR CELLS;

PARTICLE SIZE;

NANOPARTICLE; PACLITAXEL; POLYGLACTIN; ANTINEOPLASTIC AGENT; BIOMATERIAL; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; BIODEGRADABILITY; CANCER INHIBITION; CELL INTERACTION; CELL TRANSPORT; CONTROLLED STUDY; EVAPORATION; HUMAN; HUMAN CELL; MACROPHAGE; NANOANALYSIS; NANOFABRICATION; NANOTECHNOLOGY; PARTICLE SIZE; PRECIPITATION; TUMOR CELL; TUMOR GROWTH; ANIMAL; CELL DIVISION; CELL LINE; CHEMISTRY; DRUG EFFECTS; MOUSE; NEOPLASM; PATHOLOGY; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CELL LINE; HUMANS; LACTIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEOPLASMS; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID;

EID: 84909981542     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.07.030     Document Type: Article

References (24)

1. Yoo J.-W., Irvine D.J., Discher D.E., Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10:521-535.
2. Yoo J.-W., Doshi N., Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv. Drug Deliv. Rev. 2011, 63:1247-1256.
3. Choi J.-S., Seo K., Yoo J.-W. Recent advances in PLGA particulate systems for drug delivery. J. Pharm. Invest. 2012, 42:155-163.
4. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci. 2010, 351:19-29.
5. Yoo J.W., Chambers E., Mitragotri S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des. 2010, 16:2298-2307.
6. Sharma R., Saxena D., Dwivedi A.K., Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm. Res. 2001, 18:1405-1410.
7. Mundargi R.C., Babu V.R., Rangaswamy V., Patel P., Aminabhavi T.M. Nano/micro technologies for delivering macromolecular therapeutics using poly (d, l-lactide-co-glycolide) and its derivatives. J. Control. Release 2008, 125:193-209.
8. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Deliv. Rev. 2011, 63:170-183.
9. Kulkarni S.A., Feng S.S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 2013, 30:2512-2522.
10. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6:662-668.
11. Sau T.K., Pal A., Jana N., Wang Z., Pal T. Size controlled synthesis of gold nanoparticles using photochemically prepared seed particles. J. Nanopart. Res. 2001, 3:257-261.
12. Huang J., Bu L., Xie J., Chen K., Cheng Z., Li X., Chen X. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010, 4:7151-7160.
13. Mainardes R.M., Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int. J. Pharm. 2005, 290:137-144.
14. Xie H., Smith J.W. Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system. J. Nanobiotechnol. 2010, 8:18.
15. Gaumet M., Gurny R., Delie F. Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation. Int. J. Pharm. 2007, 342:222-230.
16. Liang R., Wang J., Wu X., Dong L., Deng R., Wang K., Sullivan M., Liu S., Wu M., Tao J., Yang X., Zhu J. Multifunctional biodegradable polymer nanoparticles with uniform sizes: generation and in vitro anti-melanoma activity. Nanotechnology 2013, 24:455302.
17. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989, 55:R1-R4.
18. Verrecchia T., Huve P., Bazile D., Veillard M., Spenlehauer G., Couvreur P. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J. Biomed. Mater. Res. 1993, 27:1019-1028.
19. Gaumet M., Vargas A., Gurny R., Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 2008, 69:1-9.
20. Prabha S., Zhou W.-Z., Panyam J., Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 2002, 244:105-115.
21. Garza-Licudine E., Deo D., Yu S., Uz-Zaman A., Dunbar W.B. Portable nanoparticle quantization using a resizable nanopore instrument - the IZON qNano. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2010, 5736-5739.
22. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999, 17:593-623.
23. Champion J.A., Walker A., Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 2008, 25:1815-1821.
24. Tabata Y., Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988, 9:356-362.